Medpace Holdings Inc reports results for the quarter ended in March - Earnings Summary

• Medpace Holdings Inc MEDP reported quarterly adjusted earnings of $3.20​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $2.27. The mean expectation of six analysts for the quarter was for earnings of $2.47 per share. Wall Street expected results to range from $2.43 to $2.54 per share.

• Revenue rose 17.7% to $511.04 million from a year ago; analysts expected $512.59 million.

• Medpace Holdings Inc's reported EPS for the quarter was $3.20​.

• The company reported quarterly net income of $102.59 million.

• Medpace Holdings Inc shares had fallen by 8.0% this quarter and gained 21.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.7% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Medpace Holdings Inc is $446.00

This summary was machine generated from LSEG data April 22 at 09:53 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)